Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-25-006637·EUPRAXIA PHARMACEUTICALS INC.
Schedule 13G ownership disclosure
EUPRAXIA PHARMACEUTICALS INC
Common Shares · CUSIP: 29842P105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- MANCHESTER MANAGEMENT COMPANY, LLC
Shares: 5,562,971.00 · Class: 10.4%
- MANCHESTER MANAGEMENT PR, LLC
Shares: 5,562,971.00 · Class: 10.4%
- MANCHESTER EXPLORER, L.P.
Shares: 5,337,117.00 · Class: 10.0%
- JAMES E. BESSER
Shares: 5,839,557.00 · Class: 10.9%
- MORGAN C. FRANK
Shares: 5,644,423.00 · Class: 10.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-006637
- Form type
- SCHEDULE 13G
- Filer
- EUPRAXIA PHARMACEUTICALS INC.
- CIK
- CIK 1581178
- Filed
- Nov 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership